It also interferes with protein kinase B (AKT)/glycogen synthase kinase-3 beta (GSK3β) signaling pathway, thereby exacerbating tau hyperphosphorylation at multiple residues and resulting in neuronal damage, which consequently accelerates the progression of AD 11. Here, AKT1 is linked to Alzheimer disease.